DE2164565A1 - Verfahren zur gewinnung von krebshemmenden stoffen - Google Patents
Verfahren zur gewinnung von krebshemmenden stoffenInfo
- Publication number
- DE2164565A1 DE2164565A1 DE2164565A DE2164565A DE2164565A1 DE 2164565 A1 DE2164565 A1 DE 2164565A1 DE 2164565 A DE2164565 A DE 2164565A DE 2164565 A DE2164565 A DE 2164565A DE 2164565 A1 DE2164565 A1 DE 2164565A1
- Authority
- DE
- Germany
- Prior art keywords
- cancer cells
- cancer
- animal
- antibodies
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 21
- 239000000126 substance Substances 0.000 title claims description 10
- 230000001093 anti-cancer Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 claims description 51
- 201000011510 cancer Diseases 0.000 claims description 51
- 241001465754 Metazoa Species 0.000 claims description 18
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 208000035415 Reinfection Diseases 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 3
- 238000009388 chemical precipitation Methods 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000005684 electric field Effects 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 31
- 241000282887 Suidae Species 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2164565A DE2164565A1 (de) | 1971-12-24 | 1971-12-24 | Verfahren zur gewinnung von krebshemmenden stoffen |
| FR7245990A FR2164900A1 (en) | 1971-12-24 | 1972-12-22 | Carcinostatic immunogammaglobulin prodn - from blood of animals injected with human cancer-cells |
| CH1881772A CH574246A5 (enExample) | 1971-12-24 | 1972-12-22 | |
| JP47129434A JPS4868733A (enExample) | 1971-12-24 | 1972-12-25 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2164565A DE2164565A1 (de) | 1971-12-24 | 1971-12-24 | Verfahren zur gewinnung von krebshemmenden stoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2164565A1 true DE2164565A1 (de) | 1973-06-28 |
Family
ID=5829213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2164565A Pending DE2164565A1 (de) | 1971-12-24 | 1971-12-24 | Verfahren zur gewinnung von krebshemmenden stoffen |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS4868733A (enExample) |
| CH (1) | CH574246A5 (enExample) |
| DE (1) | DE2164565A1 (enExample) |
| FR (1) | FR2164900A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO793412L (no) * | 1978-10-25 | 1980-05-06 | Benzon As Alfred | Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE691940C (de) * | 1932-12-10 | 1940-06-08 | Maria Katharina Remmets Geb Re | Verfahren zur Herstellung eines Krebsserums |
-
1971
- 1971-12-24 DE DE2164565A patent/DE2164565A1/de active Pending
-
1972
- 1972-12-22 CH CH1881772A patent/CH574246A5/xx not_active IP Right Cessation
- 1972-12-22 FR FR7245990A patent/FR2164900A1/fr active Granted
- 1972-12-25 JP JP47129434A patent/JPS4868733A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2164900B1 (enExample) | 1976-07-02 |
| JPS4868733A (enExample) | 1973-09-19 |
| FR2164900A1 (en) | 1973-08-03 |
| CH574246A5 (enExample) | 1976-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69032207T3 (de) | Einführung von bakterien in ovo | |
| DE1598832A1 (de) | Auf der Beobachtung eines Agglutinationsvorganges beruhendes Verfahren zum Nachweis von Choriongonadotropin in Koerperfluessigkeiten | |
| DE69634092T2 (de) | Herstellung von antikörpern | |
| DE2644766A1 (de) | Arzneimittel | |
| DE1720120A1 (de) | Injizierbare Zusatzmittel,Verfahren ihrer Herstellung und Verwendung und neue medizinische Zusammensetzungen,die dieses Zusatzmittel enthalten | |
| DE69220939T2 (de) | Gegengift immunsera | |
| DE2352662A1 (de) | Verfahren zur herstellung eines uebertragungsfaktors | |
| DE2164565A1 (de) | Verfahren zur gewinnung von krebshemmenden stoffen | |
| DE1617734B1 (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| DE3341367A1 (de) | Melanomdiagnosemittel mit gehalt an monoklonem spezifischen antikoerper | |
| CH392780A (de) | Verfahren zur Herstellung von intravenös anwendbaren Antikörperpräparaten humanen Ursprungs | |
| DE2620287A1 (de) | Verfahren zur wachstumsfoerderung von tieren | |
| CH650154A5 (de) | Wasserloesliche, biologisch aktive fraktion aus dem interzellularen medium des knochenmarks, verfahren zu deren gewinnung und diese enthaltende pharmazeutische zubereitung. | |
| EP0923607A1 (de) | Verfahren zur herstellung polyklonaler und monoklonaler antikörper | |
| DE2513848A1 (de) | Verfahren zur gewinnung ununterbrochener staemme von tumorzellen in vitro | |
| DE2420415A1 (de) | Eine mitogenische blutfraktion und verfahren zur herstellung derselben | |
| DE2110436C3 (de) | Verfahren zur Herstellung eines antileukopenischen und antikörperbildenden Thymusextrakts aus Kalbsthymus | |
| DE1492243B2 (de) | Injizierbare Impfstoffe | |
| DE2015804A1 (de) | Verfahren zur Herstellung eines antigenen oder allergenen Extraktes | |
| DE1617538C3 (de) | Verfahren zur Herstellung von Tetanus-Antitoxin | |
| DE2728802C2 (de) | Verfahren zum Herstellen eines antischistosomen immunologischen Mittels | |
| Wiidik et al. | Untersuchungen über die antigene Struktur von Vibrio fetus vom Rind. Das Kapsel‐oder K‐Antigen von Vibrio fetus | |
| DE2806910A1 (de) | Mittel zur desensibilisierung von flohstichen | |
| EP0183253A2 (de) | Arzneimittel enthaltend einen aus den Peyer'schen Plaques hergestellten Organextrakt zur Behandlung bei Diabetes Mellitus und Pankreatitis | |
| DE870322C (de) | Verfahren zur Herstellung von immunisierenden und sensibilisierenden Fraktionen des Serums |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |